Drug intelligence / Profile preview

oryzanol

Development stage
Unknown
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical (skin)
01

Overview

Oryzanol (commonly referred to as gamma-oryzanol or γ-oryzanol) is a mixture of ferulic acid esters of phytosterols and triterpenoids derived primarily from rice bran oil. The main constituents include cycloartenyl ferulate, 24-methylenecycloartanyl ferulate, and campesteryl ferulate[9]. Oryzanol has been used in Japan since the 1960s for menopausal symptoms, mild anxiety disorders, stomach upset (dyspepsia), and high cholesterol[7][9]. Its primary mechanism is believed to be the reduction of cholesterol absorption in the gut due to poor gastrointestinal absorption[1][2][8]. It also exhibits antioxidant properties and may have anti-inflammatory effects. While it is widely marketed as a dietary supplement for cholesterol management and sports performance enhancement (muscle growth/fatigue reduction), robust clinical evidence supporting these uses remains limited[1][2][3][5][7]. Oryzanol is approved for several indications in Japan but not as a pharmaceutical drug in most other countries.

Brand names
gamma-oryzanol
Other names
γ-oryzanolgammarizaozGu Weisu.gamma.-Orizanolhi-zoliverCaclategamma-oz

Beyond the preview

Go deeper on oryzanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oryzanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call